TRIDENT-1

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)

Near Add Your Location

Sorting 61 by

Get personalized results in 60 seconds
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials
City of Hope Comprehensive Cancer Center
Beckman Research Institute
Duarte, CA
  • Accepting patients
MemorialCare Long Beach
Long Beach, CA
  • Not yet accepting
Pacific Shores Oncology PHASE 2
Long Beach, CA
  • Accepting patients
Chao Family Comprehensive Cancer Center
University of California, Irvine
Orange, CA
  • Accepting patients
Moores Cancer Center
University of California UC San Diego Health
La Jolla, CA
  • Accepting patients
St. Joseph Heritage Healthcare
Santa Rosa, CA
  • Accepting patients
696 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(831) 888-0898

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.